Literature DB >> 19427490

Hypertension: reflections on risks and prognostication.

William B Kannel1.   

Abstract

Framingham Heart Study cardiovascular disease prospective population epidemiologic research has played an important role in the evolution of modern cohort study design and the advancement of preventive cardiology. To date no single essential factor has been identified; multiple interrelated factors are promoting increased risk for development of CHD. Elevated blood pressure has emerged as a prominent member of cardiovascular risk factors. The study's documentation of a strong link of blood pressure to development of cardiovascular events stimulated the pharmaceutical industry to develop medications for controlling blood pressure and, in turn, national campaigns to combat hypertension and its adverse vascular outlook.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427490      PMCID: PMC3719976          DOI: 10.1016/j.mcna.2009.02.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  48 in total

Review 1.  Fifty years of Framingham Study contributions to understanding hypertension.

Authors:  W B Kannel
Journal:  J Hum Hypertens       Date:  2000-02       Impact factor: 3.012

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.

Authors:  R S Vasan; M G Larson; E P Leip; W B Kannel; D Levy
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

5.  Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

Authors:  G C Fonarow; W J French; L S Parsons; H Sun; J A Malmgren
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

6.  Systolic blood pressure and mortality.

Authors:  S Port; L Demer; R Jennrich; D Walter; A Garfinkel
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

7.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.

Authors:  L G Ogden; J He; E Lydick; P K Whelton
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

8.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

9.  Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Authors:  L Ferrucci; C D Furberg; B W Penninx; M DiBari; J D Williamson; J M Guralnik; J G Chen; W B Applegate; M Pahor
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

10.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

View more
  24 in total

1.  Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.

Authors:  Brent M Egan; Jiexiang Li; Suparna Qanungo; Tamara E Wolfman
Journal:  Circulation       Date:  2013-07-02       Impact factor: 29.690

2.  Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.

Authors:  Yuriy Sirenko; Ganna Radchenko
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-02-02

3.  Hypertension and Target Organ Damage: Don't Believe Everything You Think!

Authors:  George A Mensah
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

4.  Sustained blood pressure control following discontinuation of a pharmacist intervention.

Authors:  Danielle M Wentzlaff; Barry L Carter; Gail Ardery; Carrie L Franciscus; William R Doucette; Elizabeth A Chrischilles; Kurt A Rosenkrans; Lucinda M Buys
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

5.  The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010.

Authors:  Brent M Egan; Jiexiang Li; James Small; Paul J Nietert; Angelo Sinopoli
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

6.  Whole rat DNA array survey for candidate genes related to hypertension in kidneys from three spontaneously hypertensive rat substrains at two stages of age and with hypotensive induction caused by hydralazine hydrochloride.

Authors:  Kosho Kinoshita; Mohammad Said Ashenagar; Masaki Tabuchi; Hideaki Higashino
Journal:  Exp Ther Med       Date:  2011-01-14       Impact factor: 2.447

7.  Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Authors:  Jennifer C Melvin; Crystal Rodrigues; Lars Holmberg; Hans Garmo; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Wayel Jassem; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

8.  A case report and review of the literature: cardiotoxicities after radiotherapy for breast cancer patients with high-risk factors of cardiovascular disease.

Authors:  Liuwei Tang; Haruo Matsushita; Yojiro Ishikawa; Takanori Ishida; Keiichi Jingu
Journal:  Int Cancer Conf J       Date:  2019-10-08

9.  Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.

Authors:  Emmy K Bell; Liyan Gao; Suzanne Judd; Stephen P Glasser; William McClellan; Orlando M Gutiérrez; Monika Safford; Daniel T Lackland; David G Warnock; Paul Muntner
Journal:  Am J Hypertens       Date:  2012-05-10       Impact factor: 2.689

10.  Left ventricular mass and the risk of sudden cardiac death: a population-based study.

Authors:  Jari A Laukkanen; Hassan Khan; Sudhir Kurl; Peter Willeit; Jouni Karppi; Kimmo Ronkainen; Emanuele Di Angelantonio
Journal:  J Am Heart Assoc       Date:  2014-11-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.